Companies / Industrials
TDG
TransDigm Group
Aerospace & Defense
Aerospace & DefenseAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health72
Growth86
Profitability91
Cash generation73
Balance sheet25
Dilution control84
Key ratios and five-year financials
Latest quarter revenue YoY (2026-06-27)22.5%Revenue growth (FY)19.5%Revenue CAGR (3y)17.0%Gross margin59.2%Operating margin45.6%Net margin20.0%Free cash flow margin18.1%R&D / revenue1.4%Stock comp / revenue1.4%Net debt / operating cash flow14.45xCurrent ratio2.90Diluted share count change-1.0%
| Fiscal year ending | FY 2022-09 | FY 2023-09 | FY 2024-09 | FY 2025-09 | FY 2026-09 |
|---|---|---|---|---|---|
| Revenue | $5.4B | $6.6B | $7.9B | $8.8B | $10.6B |
| Gross profit | $3.1B | $3.8B | $4.7B | $5.3B | $6.3B |
| Operating income | $2.2B | $2.9B | $3.5B | $4.2B | $4.8B |
| Net income | $866M | $1.3B | $1.7B | $2.1B | $2.1B |
| Operating cash flow | $948M | $1.4B | $2.0B | $2.0B | $2.2B |
| Capital expenditure | $119M | $139M | $165M | $222M | $274M |
| Free cash flow | $829M | $1.2B | $1.9B | $1.8B | $1.9B |
| R&D | $95M | $105M | $107M | $118M | $151M |
| Stock-based comp | $153M | $135M | $188M | $152M | $146M |
| Buybacks | $912M | $0 | $0 | $500M | $2.8B |
| Dividends | $1.1B | $38M | $2.0B | $159M | $59M |
| Cash | $3.0B | $3.5B | $6.3B | $2.8B | $2.3B |
| Total debt | $19.4B | $19.4B | $24.4B | $29.3B | $33.9B |
| Equity | -$3.8B | -$2.0B | -$6.3B | -$9.7B | -$10.0B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.